Navigation Links
BIDMC neurologist Bernard Chang, M.D., receives award for epilepsy research
Date:4/26/2011

BOSTON Bernard Chang, MD, a member of the Department of Neurology at Beth Israel Deaconess Medical Center (BIDMC) and Assistant Professor of Neurology at Harvard Medical School, received the Dreifuss-Penry Epilepsy Award at the 63rd Annual Meeting of the American Academy of Neurology, held recently in Honolulu, HI.

Established in 2001, the award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research. Former BIDMC neurologist Christopher Walsh, MD, PhD, was the award's first recipient.

Epilepsy is a brain disorder that is estimated to affect nearly 3 million individuals in the U.S., at a cost of more than $15 billion a year. Despite advances in drug therapy and surgical procedures, a significant number of individuals continue to experience uncontrolled seizures.

Chang joined the BIDMC faculty in 2002. His research focuses on malformations of cortical development, human brain disorders that are present from birth and are among the most common causes of difficult-to-control epilepsy, accounting for 15 to 20 percent of all cases. In recent years, Chang's laboratory has been studying subjects with periventricular nodular heterotopia, a unique cortical malformation that causes patients to suffer from both dyslexia and epilepsy.

"Dr. Chang's work is helping to shed light on the genetic basis of cerebral development," says Clifford Saper, MD, PhD, Chairman of the Department of Neurology at BIDMC. "This, in turn, will help lead to more precise diagnoses and prognoses for both children and adults affected by seizure disorders."

"The overall goal of our research is to better understand the ways in which epilepsy develops in the human brain," adds Chang. "In this way, we can then work to develop new therapies that can prevent seizures, minimize the risks and side effects of therapy, and improve patients' productivity and quality of life."

A graduate of Harvard College, Chang received his M.D. from the New York University School of Medicine and an M.M.Sc. in clinical investigation from Harvard Medical School. He completed residency and fellowship training at Beth Israel Deaconess Medical Center before joining the faculty in 2002. Chang is a clinical neurologist seeing adult patients in the Comprehensive Epilepsy Center at BIDMC, and is the recipient of numerous teaching awards from both Harvard Medical School and the American Academy of Neurology.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. BIDMC investigator to receive vascular biology award from the American Heart Association
2. BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation
3. First clinical trial of gene therapy for pain reported by U-M neurologists
4. Neurologists develop software application to help identify subtle epileptic lesions
5. Concussion Should Sideline Athletes: Neurologists
6. US neurologists agree on protocols for treatment of infantile spasms
7. APA gives LSUHSC psychiatry gold award for program in St. Bernard schools after Katrina
8. Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented
9. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
10. Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
11. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: